In the TCGA-GBM dataset, while neither receptor is found to be mutated, DDR2 is significantly elevated in G-CIMP subset and amplified in ME (29.8%), with comparable frequencies of copy number gain and loss observed in other subtypes. This evidence concerns the gene DDR2 and glioblastoma.